doi: 10.3892/etm.2021.10693.
Epub 2021 Sep 3.
MicroRNA-92b promotes cell proliferation and invasion in osteosarcoma by directly targeting Dickkopf-related protein 3
- PMID: 34603526
- PMCID: PMC8453327
- DOI: 10.3892/etm.2021.10693
Item in Clipboard
MicroRNA-92b promotes cell proliferation and invasion in osteosarcoma by directly targeting Dickkopf-related protein 3
Exp Ther Med.
2021 Nov.
Abstract
[This retracts the article DOI: 10.3892/etm.2017.5356.].
Copyright: © Wu et al.
Retraction of
-
MicroRNA-92b promotes cell proliferation and invasion in osteosarcoma by directly targeting Dickkopf-related protein 3.Exp Ther Med. 2018 Jan;15(1):173-181. doi: 10.3892/etm.2017.5356. Epub 2017 Oct 23. Exp Ther Med. 2018. Retraction in: Exp Ther Med. 2021 Nov;22(5):1258. doi: 10.3892/etm.2021.10693. PMID: 29250147 Free PMC article. Retracted.
Similar articles
-
MicroRNA-92b promotes cell proliferation and invasion in osteosarcoma by directly targeting Dickkopf-related protein 3.Exp Ther Med. 2018 Jan;15(1):173-181. doi: 10.3892/etm.2017.5356. Epub 2017 Oct 23. Exp Ther Med. 2018. Retraction in: Exp Ther Med. 2021 Nov;22(5):1258. doi: 10.3892/etm.2021.10693. PMID: 29250147 Free PMC article. Retracted.
-
MicroRNA-432 is downregulated in osteosarcoma and inhibits cell proliferation and invasion by directly targeting metastasis-associated in colon cancer-1.Exp Ther Med. 2022 May 30;24(1):475. doi: 10.3892/etm.2022.11402. eCollection 2022 Jul. Exp Ther Med. 2022. PMID: 35761805 Free PMC article.
-
Long non-coding RNA TUG1 promotes osteosarcoma cell proliferation and invasion through inhibition of microRNA-212-3p expression.Exp Ther Med. 2022 Apr;23(4):280. doi: 10.3892/etm.2022.11209. Epub 2022 Feb 14. Exp Ther Med. 2022. PMID: 35317440 Free PMC article.
-
MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor.Exp Ther Med. 2021 Dec;22(6):1409. doi: 10.3892/etm.2021.10845. Epub 2021 Oct 6. Exp Ther Med. 2021. PMID: 34676002 Free PMC article.
-
microRNA-605 promotes cell proliferation, migration and invasion in non-small cell lung cancer by directly targeting LATS2.Exp Ther Med. 2022 Jun 6;24(2):488. doi: 10.3892/etm.2022.11415. eCollection 2022 Aug. Exp Ther Med. 2022. PMID: 35837052 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources